Objectives: To implement a residency-based program for theteaching of evidence-based medicine in an Israeli HMO and toincorporate this effort into the HMO's routine drug policy formulationprocess.

first biocompatible pharmaceutical formulations progress to preclinical models new sustained-release drug delivery platforms for peptides, melanocortins aim to predict drug release kinetics from new ...